tirzepatide for weight loss side effects vs. Semaglutide: Which Is Better You ? Side Effects of Weight Loss

Together, these findings support further preclinical and clinical development of SR4 and related fatty acid anion transporters as a novel therapeutic class for treating metabolic diseases

Prior to label expansion, only 14% of patients diagnosed with OSA received any GLP-1 therapy, compared with 66% who received device-based treatment such as CPAP

A C, N C, A I

GLP-1 Drugs: Brand Companies Push FDA to Limit Compounding Brand companies who own GLP-1 products have been pushing the Food and Drug Administration (FDA) to limit their compounding

Data on atrial fibrillation outcomes with GLP-1 therapy usually come from secondary analyses rather than dedicated rhythm trials, which limits definitive conclusions

Youve got tools, people, and plans that meet you exactly where you are